Literature DB >> 15081538

Cysteine-dependent immune regulation by TRX and MIF/GIF family proteins.

Norihiko Kondo1, Yasuyuki Ishii, Aoi Son, Junko Sakakura-Nishiyama, Yong-Won Kwon, Masaki Tanito, Yumiko Nishinaka, Yoshiyuki Matsuo, Toshinori Nakayama, Masaru Taniguchi, Junji Yodoi.   

Abstract

Thioredoxin (TRX) superfamily proteins that contain a conserved redox-active site -Cys-Xa.a.-Xa.a.-Cys- includes proinflammatory cytokine, macrophage migration inhibiting factor (MIF) and the immune regulatory cytokine, glycosylation inhibiting factor (GIF) in which Cys-60 is cysteinylated. In this report, we have analyzed the functional interaction between TRX and MIF/GIF. The stable Jurkat T cell line transfected with human TRX gene (TRX-transfectant) was highly resistant to hydrogen peroxide-induced apoptosis, but not the cell line transfected with vector (mock-transfectant). The expression level of MIF/GIF protein of TRX-transfectant was lower than that of mock-transfectant. Conversely, the expression level of intracellular TRX protein in CD4(+)-T cells derived from MIF -/- mice were significantly higher than that from background BALB/c mice. These findings collectively suggest that oxidative stress-induced apoptosis on T lymphocytes might be protected by the reciprocal regulation of TRX and MIF/GIF expression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15081538     DOI: 10.1016/j.imlet.2003.11.030

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  11 in total

Review 1.  Discovery of ATL: an odyssey in restrospect.

Authors:  Junji Yodoi; Michiyuki Maeda
Journal:  Int J Hematol       Date:  2011-11-09       Impact factor: 2.490

2.  Macrophage Migration Inhibitory Factor: A Novel Inhibitor of Apoptosis Signal-Regulating Kinase 1-p38-Xanthine Oxidoreductase-Dependent Cigarette Smoke-Induced Apoptosis.

Authors:  Jonathan Fallica; Lidenys Varela; Laura Johnston; Bo Kim; Leonid Serebreni; Lan Wang; Mahendra Damarla; Todd M Kolb; Paul M Hassoun; Rachel Damico
Journal:  Am J Respir Cell Mol Biol       Date:  2016-04       Impact factor: 6.914

Review 3.  Cysteine/cystine redox signaling in cardiovascular disease.

Authors:  Young-Mi Go; Dean P Jones
Journal:  Free Radic Biol Med       Date:  2010-12-03       Impact factor: 7.376

Review 4.  Increased plasma thioredoxin levels in patients with sepsis: positive association with macrophage migration inhibitory factor.

Authors:  Susannah K Leaver; Niall S MacCallum; Vasisht Pingle; Matthew B Hacking; Gregory J Quinlan; Timothy W Evans; Anne Burke-Gaffney
Journal:  Intensive Care Med       Date:  2009-09-15       Impact factor: 17.440

Review 5.  Multiple sclerosis: molecular mechanisms and therapeutic opportunities.

Authors:  Djordje Miljković; Ivan Spasojević
Journal:  Antioxid Redox Signal       Date:  2013-04-22       Impact factor: 8.401

Review 6.  Redox regulation of cell survival by the thioredoxin superfamily: an implication of redox gene therapy in the heart.

Authors:  Md Kaimul Ahsan; Istvan Lekli; Diptarka Ray; Junji Yodoi; Dipak K Das
Journal:  Antioxid Redox Signal       Date:  2009-11       Impact factor: 8.401

Review 7.  The redox proteome.

Authors:  Young-Mi Go; Dean P Jones
Journal:  J Biol Chem       Date:  2013-07-16       Impact factor: 5.157

8.  Systemic and sustained thioredoxin analogue prevents acute kidney injury and its-associated distant organ damage in renal ischemia reperfusion injury mice.

Authors:  Kento Nishida; Hiroshi Watanabe; Masako Miyahisa; Yuto Hiramoto; Hiroto Nosaki; Rui Fujimura; Hitoshi Maeda; Masaki Otagiri; Toru Maruyama
Journal:  Sci Rep       Date:  2020-11-26       Impact factor: 4.379

Review 9.  Progress in the mechanism and targeted drug therapy for COPD.

Authors:  Cuixue Wang; Jiedong Zhou; Jinquan Wang; Shujing Li; Atsushi Fukunaga; Junji Yodoi; Hai Tian
Journal:  Signal Transduct Target Ther       Date:  2020-10-27

10.  Long-Acting Thioredoxin Ameliorates Doxorubicin-Induced Cardiomyopathy via Its Anti-Oxidative and Anti-Inflammatory Action.

Authors:  Ryota Murata; Hiroshi Watanabe; Hiroto Nosaki; Kento Nishida; Hitoshi Maeda; Motohiro Nishida; Toru Maruyama
Journal:  Pharmaceutics       Date:  2022-03-03       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.